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Retinoic acid (RA) has been shown to inhibit melanogenesis 
in B 16 mouse melanoma cells (B 16 cells). On the other hand, 
it has been reported that RA increases protein kinase C (PKC) 
activity in these cells. Further investigation was carried out to 
identify the PKC subspecies eXf ressed in B16 cells and to 
examine the changes in the leve of each PKC subspecies by 
RA treatment. Hydroxyapatite column chromatography, 
immunoblot analysis, and kinetic analysis have shown that 
B16 cells express the a subspecies of PKC. Northern blot 
analysis has indicated that these cells normally express 
mRNA for the a, d, €. and , subspecies. Upon treat-
P rotein kinase C (PKC) is generally accepted to play a pivotal role in physiologic cellular responses to external signals [1]. Molecular cloning and biochemical analysis of this enzyme have revealed that PKC is a family of multiple subspecies that have subtly different enzyme­
logic characteristics [1]. Initially, four cDNA clones, a, PI, fJIJ., and 
)I, were isolated, which are highly conserved among various mam­
malian species. PKC from rat brain tissue is normally resolved into 
three subfractions, types I, II, and III, upon hydroxyapatite column 
chromatography [2], which correspond to the enzymes encoded by 
the )I,P(fJI plusfJII), and a cDNA clones, respectively [3]. Recently, 
four additional cDNA clones of PKC. J, E, C, and " have been 
isolated [4,5]. Some members of the PKC family exhibit distinct 
patterns of tissue expression and intracellular localization. Each 
PKC subspecies probably has a distinct function in the processing 
and modulation of a variety of physiologic and pathologic responses 
to external signals [1]. 
Retinoic acid (RA) has been shown to inhibit melanogenesis in 
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B16 cells: B16 mouse melanoma cells 
DO: diolein 
EDTA: ethylenediaminetetraacetic acid 
EGTA: ethylene glycol bis (p-aminoethyl ether)-N,N,N',N'-tetra-
acetic acid 
FPLC: fast-protein liquid chromatography 
OAG: 1-0Ieoyl-2-acetyl-glycerol 
PBS: phosphate-buffered saline 
PKC: protein kinase C 
PMSF: phenylmethylsulfonyl fluoride 
PS: phosphatidylserine 
RA: retinoic acid 
SDS: sodium dodecyl sulfate 
TP A: 12-0-tetradecanoyl-phorbol-13-acetate 
ment ofB 16 cells with 1 JiM RA for 48 h, both the activity of 
the a-subspecies and the level of mRNA for the a subspecies 
were increased, resulting in the decrease of melanin polymer 
formation and tyrosinase activity. Neither the enzyme activi­
ties nor mRNA for the p and i' subspecies were detected in 
either the RA-treated or untreated cells. The levels of mRNA 
for the d, €, and , subspecies were not altered by RA treat­
ment. The demonstration of a selective increase of the a 
subspecies of PKC is a unique finding. ] Invest Dermatol1 00: 
2048-2088,1993 
B 16 mouse melanoma cells (B 16 cells) [6]. On the other hand, it has 
been reported that RA increases PKC activity in these cells [7], but 
the subspecies involved in the increase in PKC activity has not been 
investigated yet. 
The present studies were undertaken to identify the PKC subspe­
cies expressed in B 16 cells and to examine the changes in the level of 
each PKC subspecies by RA treatment in these cells. The relation­
ship between the increased activity of PKC and the inhibition of 
melanogenesis in RA-treated B16 cells will be discussed herein. 
MATERIALS AND METHODS 
Reagents All-trans-RA was obtained from Sigma. [)l-32p]ATP 
and [a-32p]dCTP were obtained from New England Nuclear. 
Phenylmethylsulfonyl fluoride (PMSF) and leupeptin were pur­
chased from Wako Pure Chemical (Osaka) and Peptide Institute 
(Osaka), respectively. The oligopeptide MBP 4-14, corresponding to 
the major phosphorylation site of myelin basic protein, was used as a 
PKC-specific phosphate acceptor [8]. Phosphatidylserine (PS) and 
diolein (DO) were purchased from Serdary Research Laboratories. 
Calf thymus H1 histone was prepared by the method of Oliver et al 
[9]. 
Cell Culture B16 cells were cultured in Eagle's minimal essen­
tial medium supplemented with 10% fetal calf serum at 37· C in a 
humidified atmosphere of 5% CO2 in air. Following a 24-h cell-at­tachment period, the culture medium was changed to one contain­
ing 1 pM RA dissolved in 0.1 % ethanol or 0.1 % ethanol (control). 
Cells were used in their exponential growth phase. At 48 h after the 
addition ofRA, growth media was discarded and the culture dishes 
wert· washed three times with phosphate-buffered saline (PBS) to 
remove excess media. Cells were harvested by scraping in PBS. 
Melauin Measurement The melanin content was measured by a 
modification of the method of Hosoi et al [6]. Cells were pelleted 
and solubilized by treatment with 1 ml of 1 N NaOH and 10% 
dimethyl sulfoxide at 80·C for 2 h. The absorbance was read at 470 
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run and the melanin content per mg protein was calculated and 
expressed in percent melanin content as compared to control cells (= 100%). Protein content was determined by the method of Brad­
ford [10]. 
Tyrosinase Assay Tyrosinase activity was assayed as described by 
Iwata et al [11] with a slight modification. Cells were pelleted and 
lysed in 0.5% sodium deoxycholate for 15 min at 4·C, and the 
solution was used as enzyme solution. Tyrosinase activity was mea­
sured colorimetrically as dopa oxidase activity. The standard reac­
tion mixture consisted of 2 ml of 0.1 % L-dopa in 0.1 M potassium 
phosphate buffer (PH 6.8), and 0.5 ml of an appropriate enzrm:e 
solution. The reaction was carried out at 37·C. Absorbance atA75 
run, the absorption maximum of dopachrome, was measured for 10 
min. The enzyme activity was calculated as !l£/min and expressed 
in percent tyrosinase activity as compared to control cells (= 100%). 
Preparation ofPKC All operations were performed at 0-4 ·C. 
B16 cells (5-9 X 107 cells) were suspended in 10 volumes of 0.25 
M sucrose containing 20 mM Tris/HCI (PH 7.5), 10 mM ethyl­
ene glycol bis(fl-aminoethyl ether)-N,N,N',N',-tetraacetic acid 
(EGTA), 2 mM ethylenediaminetetraacetic acid (EDTA), 1 mM 
PMSF, and 20 p.g/ml leupeptin. The cells were lysed by sonication 
using three 15-second bursts, and centrifuged at 100,000 X g for 30 
min, and the supernatant was employed as cytosol extract. The 
pellet was lysed by sonication using eight 15-second bursts in the 
above buffer containing Triton X-I00 (1 % v /v), and centrifuged at 
100,000 X g for 30 min. The supernatant was used as membrane 
extract. 
PKC Purification by Mono Q Column Chromatograpby 
The cytosol and membrane extracts were applied separately to a 
Mono Q HR 5/5 column (Pharmacia 0.5 X 5 cm), which was con­
nected to a fast-protein liquid chromatography (FPLC) system 
(Pharmacia) and equilibrated beforehand with Buffer A (20 mM 
Tris/HCI (PH 7.5) containing 0.5 mM EDTA, 0.5 mMEGTA, and 
10 mM 2-mercaptoethanol). After washing the column with 30 ml 
of Buffer A, PKC was eluted by increasing the concentration of 
NaCl linearly from 0 to 0.6 M in 15 ml of Buffer A at a flow rate of 
0.5 ml/min. Fractions of 1 ml each were collected. 
PKC Purification by Hydroxyapatite Column Chromatog­
rapby The cytosol extract was applied to a DEAE cellulose (DE 
52, Whatman) column (1.5 X 7 cm), which was equilibrated be­
forehand with Buffer A. Mter washing the column with five col­
umn volumes of Buffer A containing 20 mM NaCI, PKC was eluted 
batch-wise with 5 ml of Buffer A containing 150 mM NaC!. This 
eluate was applied to a hydroxyapatite column (0.78 X 13.5 cm, 
type C, Koken Ltd, Tokyo), connected to an FPLC system and 
equilibrated beforehand with Buffer B [20 mM potassium phos­
phate (PH 7.5), containing 0.5 mM EGTA, 0.5 mM EDTA, 10% 
(v/v) glycerol, and 10 mM 2-mercaptoethanol]. The column was 
washed with 28 ml of Buffer B, and the PKC subspecies were eluted 
by increasing the concentration of potassium phosphate linearly 
from 20 to 215 mM in 84 ml of Buffer B at a flow rate of 0.4 
ml/min. Fractions of 1 ml each were collected. 
PKC from rat brain was purified by DE 52 and hydroxyapatite 
column chromatographies as described [12]. 
PKC Assay PKC from B16 cells and rat brain was assayed by 
measuring the incorporation of 32p from [y-32p]ATP into the PKC­
specific synthetic substrate MBP 4-14' The standard reaction mixture 
(50 fll) contained 20 mM Tris/HCI (PH 7.5), 5 mM MgCl2, 10 p.M [y_32P]ATP, 25 p.M MBP4_14, PS (8 p.g/ml), DO (0.8 p.g/ml), 0.3 
mM CaCl2, and 10 p.l of enzyme. Basal activity was measured in the presence of 0.5 mM EGTA instead of PS, DO, and CaCI2. After incubation for 15 min at 30·C, 30 p.l of the reaction mixture was 
spotted onto P81 paper (Whatman). The paper was washed five 
times for 5 min each by immersion in 50 ml of 75 mM H3P04• The radioactivity was quantitated using a scintillation spectrometer by 
Cerenkov counting. 
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Immunoblot Analysis The active cytosol PKC fractions from 
Mono Q column chromatography were subjected to 10% sodium 
dodecyl sulfate (SDS) - polyacrylamide gel electrophoresis, and 
transferred to nitrocellulose filters. The filters were incubated over­
night at room temperature with Tris/NaCI buffer [10 mM Tris/ 
HCI (PH 7.5) containing 150 mM NaCI] containing 3% gelatin and 
0.02% NaN3, and then allowed to react with polyclonal antibodies specific to the a, p, and y subspecies (C�V5a-a, C�VJJ-a, and 
CK" V3y-a, respectively [13]) (approximately 5 p.g/ml in Tris/NaCI buffer containing 0.1 % gelatin) for 1 h at room temperature. Mter 
washing with Tris/NaCI buffer containing 0.05% Tween 20, the 
filters were incubated for 30 min with biotinylated anti-rabbit IgG 
antibody and subsequently with avidin-biotinylated horseradish 
peroxidase complex (Vectastain, Vector Laboratories). The color 
reaction was carried out using diaminobenzidine tetrahydrochlor­
ide and H202. 
Northern Blot Analysis B 16 cells were treated with or without 
1 p.M RA for 48 h as described above. Total RNA were isolated from 
RA-treated and control B16 cells by homogenization in guanidine 
isothiocyanate buffer [4 M guanidine isothiocyanate, 25 mM so­
dium acetate (PH 6.0), and 0.5% p-mercaptoethanol] and by ultra­
centrifugation through a 5.7 M CsCI cushion. Approximately 25 p.g 
of denatured total RNA were fractionated on 1.0% agarose gel 
containing 0.67 M formaldehyde, 0.2 M morpholinopropanesul­
fonic acid, 0.05 M sodium acetate, and 0.01 M EDTA. After electro­
phoresis, the RNA were transferred to nitrocellulose filters by capil­
lary action in 10 X SSC [1 X SSC = 0.15 MNaCI,O.015 M sodium 
citrate (PH 7.2)1 and fixed to the nitrocellulose by baking. 
The levels of mRNA for the a, p, y, 0, E, and , subspecies were 
determined by hybridization blot analysis using each of the cDNA 
clones [14-16]. 
The cDNA clones were labeled with [a-32P]dCTP by random 
primer kit (Takara, Kyoto) and hybridizations were conducted with 
approximately 2-5 X 107 cpm of 32P-Iabeled cDNA clones. The 
nitrocellulose filters with the fixed RNA were hybridized with the 
32P-Iabeled probes for each PKC subspecies in. buffer containing 
10 mM Tris/HCl (PH 7.4), 40% formamide, 2 X SSC, 1 X 
Denhardt's solution (0.02% each of polyvinylpyrrolidone, bovine 
serum albumin, and Ficoll 400), and 0 . . 02 mgJml salmon sperm 
DNA; incubations were carried out overnight in a shaking water 
bath at 42·C. 
The nitrocellulose filters were washed twice for 20 min each in 
1 X SSC containing 0.1 % SDS at room temperature and then twice 
for 20 min each in 0.1 X SSC containing 0.1% SDS at 55·C. The 
filters were air-dried and autoradiographed for 18-48 h at -70·C 
with an intensifying screen. Some filters were stripped of labeled 
probe by boiling in water and subsequently hybridized with other 
32P-Iabeled cDNA probes. 
The level of mRNA for P-actin was determined in the same 
manner with a cDNA for p-actin. 
RESULTS 
Inhibition ofMeianogenesis by RA In confirmation of an ear­
lier report [6], RA markedly inhibited melanogenesis of B16 cells, 
although this retinoid did not inhibit cell growth to any significant 
extent (Fig 1). RA caused approximately 35% and 65% inhibition of 
the melanin content and tyrosinase activity, respectively. 
Increase in PKC Activity by RA Cytosol and membrane PKC 
activities were assayed separately after Mono Q column chromatog­
raphy (Fig 2). Treatment of B 16 cells with RA resulted in an approx­
imately twofold increase in cytosol PKC activity. This result is 
comparable to that of the earlier report [7]. Membrane PKC activity, 
however, was not altered by RA to any appreciable extent. 
Identification ofPKC Subspecies Cytosol PKC activities from 
both RA-treated and control B16 cells were resolved into a single 
fraction upon hydroxyapatite column chromatography (Fig 3 A,B). 
Both enzyme peaks appeared at the concentrations of potassium 
phosphate that correspond to the elution position of the a subspe-
206S OKA ET AL 
A B 
(%) 
100 
50 
0 
Figure 1. Effect of RA on melanin content and tyrosinase activity in B 16 
cells. B16 cells were treated without (A) or with (B) 1 pM RA for 48 h. 
Melanin content (solid bar) and tyrosinase activity (open bar) were deter­
mined. Data were expressed in percent melanin content and percent tyrosin­
ase activity as compared to control cells (= 100%). 
cies from rat brain (Fig 3C). An RA-induced increase in PKC activ­
ity was also observed following hydroxyapatite chromatography. 
PKC subspecies expressed in B16 cells were analyzed by immu­
noblot analysis (Fig 4). PKC fractions from Mono Q column chro­
matography of both RA-treated and control B16 cells reacted with 
the antibody specific to the a subspecies, and showed an approxi­
mate molecular mass of 80 kDa. There were much greater amounts 
of the immunoreactive a subspecies in samples from RA-treated 
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Figure 2. Mono Q column chromatography ofPKC from RA-treated and 
control B 16 cells. B 16 cells were treated with or without 1 pM RA for 48 h. 
Cytosol (A) and membrane (B) extracts were subjected separately to Mono 
Q HR 5/5 column chromatography. and PKC activity was assayed. Data 
were obtained by subtracting the activity measured in the presence ofEGT A 
(0.5 mM) from that measured in the presence of PS (8 pg/rnl). DO (0.8 
pg/ml). and CaClz (0.3 mM) for each fraction. Solid circles, RA-treated B16 
cells; open circles, control B16 cells; line, NaCI concentration. 
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Figure 3. Hydroxyapatite column chromatography of PKC from RA­
treated and control B 16 cells. B 16 cells were treated with or without 1 pM 
RA for 48 h. PKC from the cytosol extracts of B16 cells and rat brain were 
purified by DE 52 and hydroxyapatite column chromatographies. and PKC 
activity was assayed. (A) PKC from RA-treated B16 cells. (B) PKC from 
control B16 cells. (C) PKC from rat brain. Solid circles, in the presence ofPS 
(8 pg/rnl). DO (0.8 pg/ml). and CaClz (0.3 mM); open circles, in the presence 
ofEGTA (0.5 mM) instead ofPS. DO. and CaCI2 ; line, potassium phosphate 
concentration. 
cells. PKC fractions of both RA-treated and control B16 cells did 
not react with the antibodies specific to the p and)' subspecies. 
Kinetic analysis showed that PKC from both RA-treated and 
control B16 cells responded well to PS plus DO at higher concen­
trations of Ca++ (Fig S A,B). This property is comparable to that of 
the a subspecies of PKC from rat brain (Fig SC). 
Expression of mRNA for PKC Snbspecies Expression of 
mRNA for PKC subspecies from both control and RA-treated B16 
cells was examined by Northern blot analysis. The results are shown 
in Fig 6. mRNA for the a, d, E, and , subspecies were normally 
expressed in B16 cells. mRNA for the p and)' subspecies were not 
detected. Upon treatment with 1 pM RA for 48 h, only the level of 
mRNA for the a subspecies (approximately 4.5 and 9.0 kb) was 
markedly increased, whereas the levels of mRNA for the d, E, and , 
subspecies were not altered to any appreciable extent. m.RNA for 
the p'and )' subspecies were not detected following RA treatment. 
DISCUSSION 
In the present study, we have demonstrated that B 16 cells normally 
express mRNA for the a, d, E, and 'subspecies of PKC and that RA 
selectively increases both mRNA for the a subspecies and the a 
subspecies protein. 
RA changes the structural configuration of its nuclear receptor 
protein enabling it to bind to a specific receptor domain (the RA-re­
sponsive element) of a target gene, where it up- (or down-) regulates 
transcription [17]. The evidence that RA increases mRNA for the a 
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Figure of. Immunoblot analysis of PKC subspecies from RA-treated and 
control B16 cells. The active cytosol PKC fractions from Mono Q column 
chromatography were subjected to SDS-polyacrylarnide gel electrophoresis 
and transferred to nitrocellulose filters to react with polyclonal antibodies 
specific to each PKC subspecies. (A-C) Immunoblot analysis using poly­
clonal antibodies specific to the a, P. and)l subspecies. respectively. Lanes 1, 
4, and 7: PKC fractions from RA-treated B16 cells. Lanes 2,5, and 8: PKC 
fractions from control B 16 cells. Lanes 3, 6, and 9: the a. P. and )I subspecies 
of PKC from rat brain. respectively. Arrow, the positions of PKC. Size of 
PKC is given in kDa. 
subspecies demonstrated in this study raises the possibility that the 
gene for the a subspecies ofPKC has an RA-responsive element and 
can be regulated directly by the RA receptor. However. it is also 
possible that the changes in the levels of mRNA for the a subspecies 
and the a subspecies protein observed in the present study. could 
result from changes in turnover of mRNA for the a subspecies 
DLL-L-L-LLL-L-L-L��CC� 
'I 5 a , I 3 I 8 3 
CaCh (-logM) 
Figure 5. Activation ofPKC from RA-treated and control B16 cells by PS 
plus DO at various concentrations of Ca++. PKC fractions from Mono Q 
column chromatography were assayed. (A) PKC fromRA-treatedB16 cells. 
(B) PKC from control B16 cells. (C) The a subspecies of PKC from rat 
brain. Solid circles, in the presence ofPS (8 ,ugjml) plus DO (0.8 ,ugjml); open 
circles, in the absence of PS and DO. Where indicated with arrows, EGTA 
(0.5 mM) was added instead of CaCI2• Results were normalized to the 
maximum activiry obtained in the presence of PS plus DO at the optimum 
concentration of CaCI2 . 
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Figure 6. Northern blot analysis of mRNA for PKC subspecies from RA­
treated and control B 16 cells. B 16 cells were treated with or without 1 pM 
RA for 48 h. Total RNA were denatured, electrophoresed. transferred to 
nitrocellulose filters. and hybridized with each of the 32P-Iabeled probes for 
PKC. (A -F) Northern blot analysis using specific probes to the a. P. y. d. E. 
and , subspecies. respectively. (G) Northern blot analysis using a specific 
probe to p-actin. Lanes 1, 3, 5, 7,9, 11, and 13: total RNA from RA-treated 
B16 cells. Lanes 2,4,6,8, to, 12, and 14: total RNA from control B16 cells. 
The size markers used here are 28s and 18s mouse rRNA. 
and/or the a subspecies protein and not from the regulation of gene 
transcription per se. 
The mechanism by which RA inhibits melanogenesis is not yet 
well understood. We have previously suggested that the activation 
of PKC plays a role in the inhibition of melanogenesis in B16 cells 
because PKC activators such as 12-0-tetradecanoyl-phorbol-13-ac­
etate (TPA), 1-oleoyl-2-acetyl-glycerol (OAG) , and linoleic acid 
inhibit melanogenesis in these cells [18,19]. However, as these 
agents activate all subspecies of PKC in vitro [1] and B16 cells 
express at least four (a, 0, E, and 0 kinds of subspecies, it is not clear 
which subspecies is involved in the inhibition of melanogenesis. In 
this report, we have shown that RA selectively increases the level of 
the a subspecies of PKC in B16 cells, resulting in the decrease of 
melanin polymer formation and tyrosinase activity. However, RA 
does not directly activate isolated PKC from B16 cells in vitro (data 
not shown). Although the exact relation of PKC to melanogenesis 
remains unclear, we propose that the increased amount of the a 
subspecies induced by RA mediates at least some of the actions of RA 
in the process of melanogenesis inhibition in B16 cells. Further 
understanding of this potential role of the a subspecies in regulation 
of melanogenesis requires the identification and molecular charac­
terization of physiologic substrates of this enzyme. 
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